Autistic Disorder Clinical Trial
Official title:
Improving Social Cognition for Adults With Autism Spectrum Disorder by the Serious Game JeStiMulE Versus Classic Video Game Stimulation Not Improving Social Cognition
The serious game "JeStiMulE" (Educational Game for Multisensory Stimulation of Children with
developmental disorders), developed by the Autism Resources Center of Nice, was created to
teach social cognition including emotion recognition in context, for children and adolescents
with autism. In a previous study, JeStiMulE has demonstrated efficacy in a population of
young people aged 6-17 years old with high and low levels of autism.
According to the recommendations of the 2011 HAS, disorders of social interactions are the
most persistent troubles of the autistic triad in life.
It seems essential to us to be able to offer young adults with autism, rehabilitation methods
adapted to their trouble, and to observe whether JeStiMulE could be one of them.
This study researches the effectiveness of the serious game JeStiMulE in the improvement
social cognition for adults with autism versus controls.
The main goal is:
- Comparing the improvement in social cognition among adults with autism using the serious
game JeStiMulE or not.
Two groups will be formed: a first one of fifteen adults with a diagnosis of autism
objectified, this group will use JeStiMulE and will be compared to a control group of adults
with autism, using another video game, not aimed to improve social cognition.
The objective of JeStiMulE players will be ending the game after a learning period and two
playing periods (with emotional words and idioms, including three modules each). The groups
will be matched with their nonverbal IQ through Raven matrices and visual memory tasks
(WAIS).
The control group will also be stimulated through a video game, not specialized in improving
social cognition.
The primary outcome will be assessed by the emotion recognition at the FEEST of Ekman test:
by the number of emotions recognized on faces, compared to the number of emotion presented
through this test.
The secondary outcomes will be:
- The rest of social cognition improvement by several tests (the theory of mind with the
score of the Tom-15, the intention with the score Sarfati cartoons, empathy with a
self-administered questionnaire: EQ / AQ).
- The impact on the quality of life, verbal fluency of emotional words, and the feedback
from JeStiMulE players will also be seen as a secondary outcome.
A lot of studies found a deficit in social cognition for individuals with autism, especially
in emotions recognition, more precisely the negative emotions. These studies refer to the
population of adults with high-functioning autism, but few reports results for low levels.
The serious game "JeStiMulE" (Educational Game for Multisensory Stimulation of Children with
developmental disorders), developed by the Autism Resources Center of Nice, was created to
teach social cognition including emotion recognition in context, for children and adolescents
with autism, by developing a fun game environment; so that children and adolescents with
autism spectrum disorder can experience virtual reality in reciprocal social interactions
(emotions recognition, emotional gestures, communication, ...). In a previous study,
JeStiMulE has demonstrated its efficacy in a population of young people aged 6-17 years old
with high and low levels of autism.
According to the recommendations of the 2011 HAS, disorders of social interactions are the
most persistent troubles of the autistic triad in life. But, early stimulation offered by
educational provision and care has a positive influence on the development of these
disorders.
It seems essential to us to be able to offer young adults with autism, rehabilitation methods
adapted to their trouble, and to observe whether JeStiMulE could be one of them.
This study researches the effectiveness of the serious game JeStiMulE in the improvement of
social cognition for adults with autism versus controls.
The main goal is:
- Comparing the improvement in social cognition among adults with autism using the serious
game JeStiMulE or not.
Two groups will be formed: a first group of fifteen adults with a diagnosis of autism
objectified. This group will use JeStiMulE and will be compared to a control group of fifteen
adults with autism, using another video game, not aimed to improve social cognition.
The objective of JeStiMulE players will be ending the game after a learning period and two
playing periods (with emotional words and idioms, which include three modules each). The
session ends when the module is completed, which is approximately one hour per module, or 6
sessions of play. The groups will be matched with their nonverbal IQ through Raven matrices
and visual memory tasks (WAIS).
The control group will also be stimulated through a video game, not specialized in improving
social cognition.
The primary outcome will be assessed by the emotion recognition at the FEEST of Ekman test:
by the number of emotions recognized on faces, compared to the number of emotion presented
through this test.
The secondary outcomes will be:
- The rest of social cognition improvement by several tests (the theory of mind with the
score of the Tom-15, the intention with the score of the Sarfati BD, empathy with a
self-administered questionnaire: EQ / AQ).
All these elements will be tested before and after the playing session to assess improvement
of social cognition.
- The impact on the quality of life, verbal fluency of emotional words, and the feedback from
JeStiMulE players will also be seen as a secondary outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03222375 -
SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
Completed |
NCT01617460 -
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
|
Phase 3 | |
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Completed |
NCT01400269 -
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
|
N/A | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
Completed |
NCT00692315 -
Treating Oxidative Stress in Children With Autism
|
N/A | |
Completed |
NCT00365859 -
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
|
Phase 3 | |
Completed |
NCT00198107 -
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
|
Phase 3 | |
Completed |
NCT00095420 -
Relationship Training for Children With Autism and Their Peers
|
N/A | |
Completed |
NCT00027404 -
Study of Fluoxetine in Adults With Autistic Disorder
|
N/A | |
Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
Completed |
NCT04820998 -
Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
|
||
Withdrawn |
NCT05413187 -
A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder
|
Phase 2 | |
Recruiting |
NCT02275455 -
Design Of WELL Being Monitoring Systems, Application in Autism
|
N/A | |
Completed |
NCT02766101 -
Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
|
N/A | |
Completed |
NCT01977248 -
Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12
|
N/A | |
Terminated |
NCT01592773 -
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 |